| Post-translational modifications and diastolic calcium leak associated to the novel RyR2-D3638A mutation lead to CPVT in patient-specific hiPSC-derived cardiomyocytes I Acimovic, MM Refaat, A Moreau, A Salykin, S Reiken, Y Sleiman, ... Journal of clinical medicine 7 (11), 423, 2018 | 50 | 2018 |
| Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes Y Sleiman, M Souidi, R Kumar, E Yang, F Jaffré, T Zhou, A Bernardin, ... EBioMedicine 60, 2020 | 22 | 2020 |
| “Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models? Y Sleiman, A Lacampagne, AC Meli Cell Death & Disease 12 (11), 1041, 2021 | 20 | 2021 |
| The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy JB Reisqs, A Moreau, A Charrabi, Y Sleiman, AC Meli, G Millat, V Briand, ... Clinical and Translational Medicine 12 (3), 2022 | 14 | 2022 |
| Oxygen is an ambivalent factor for the differentiation of human pluripotent stem cells in cardiac 2D monolayer and 3D cardiac spheroids M Souidi, Y Sleiman, I Acimovic, J Pribyl, A Charrabi, V Baecker, ... International Journal of Molecular Sciences 22 (2), 662, 2021 | 10 | 2021 |
| Spironolactone as a potential new treatment to prevent arrhythmias in arrhythmogenic cardiomyopathy cell model JB Reisqs, A Moreau, Y Sleiman, A Charrabi, A Delinière, F Bessière, ... Journal of Personalized Medicine 13 (2), 335, 2023 | 6 | 2023 |
| Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes Y Sleiman, S Reiken, A Charrabi, F Jaffré, LR Sittenfeld, JL Pasquié, ... Stem Cell Research & Therapy 14 (1), 266, 2023 | 4 | 2023 |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells JB Reisqs, A Moreau, Y Sleiman, M Boutjdir, S Richard, P Chevalier Frontiers in Physiology 14, 1191965, 2023 | 4 | 2023 |
| Lethal, hemorrhagic, and necrotic effects of Montivipera bornmuelleri venom A Abi-Rizk, M Rima, SH Bloquet, R Sadek, Y Sleiman, Z Fajloun, ... Current herpetology 36 (1), 58-62, 2017 | 4 | 2017 |
| Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart S Jelinkova, Y Sleiman, P Fojtík, F Aimond, A Finan, G Hugon, ... International Journal of Molecular Sciences 22 (9), 5025, 2021 | 3 | 2021 |
| Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1 VKM Ginjupalli, M Cupelli, JB Reisqs, Y Sleiman, N El-Sherif, G Gourdon, ... Frontiers in Physiology 14, 1257682, 2023 | 1 | 2023 |
| Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants Y Sleiman, JB Reisqs, RB Tan, F Cecchin, M Chahine, M Boutjdir Stem Cell Research, 103608, 2024 | | 2024 |
| Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 mice M Cupelli, VKM Ginjupalli, JB Reisqs, Y Sleiman, N El-Sherif, G Gourdon, ... Biomedicine & Pharmacotherapy 180, 117562, 2024 | | 2024 |
| Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model Y Sleiman, JB Reisqs, M Boutjdir International Journal of Molecular Sciences 25 (17), 9155, 2024 | | 2024 |
| Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy M Souidi, J Resta, H Dridi, Y Sleiman, S Reiken, K Formoso, S Colombani, ... Journal of Cachexia, Sarcopenia and Muscle 15 (2), 536-551, 2024 | | 2024 |
| Modeling and drug screening of inherited short-coupled polymorphic ventricular tachycardia using patient derived tissue Y Sleiman, S Reiken, A Charrabi, F Jaffré, LR Sittenfeld, JL Pasquié, ... Journal of Molecular and Cellular Cardiology 173, S79-S80, 2022 | | 2022 |
| " Ryanopathies" and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?(vol 12, 1041, 2021) Y Sleiman, A Lacampagne, AC Meli CELL DEATH & DISEASE 13 (12), 2022 | | 2022 |
| Correction:“Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models? Y Sleiman, A Lacampagne, AC Meli Cell Death & Disease 13 (12), 1014, 2022 | | 2022 |
| Modeling inherited short-coupled polymorphic ventricular tachycardia using patient specific hiPSC-derived cardiomyocytes and CRISPR/Cas 9 technology Y Sleiman, M Souidi, R Kumar, E Yang, F Jaffré, T Zhou, A Bernardin, ... Archives of Cardiovascular Diseases Supplements 14 (1), 89, 2022 | | 2022 |
| Modeling inherited short-coupled polymorphic ventricular tachycardia using patient specific hiPSC-derived cardiomyocytes and CRISPR/Cas 9 technology Y Sleiman, M Souidi, R Kumar, E Yang, F Jaffré, T Zhou, A Bernardin, ... Archives of Cardiovascular Diseases Supplements 13 (4), 331-332, 2021 | | 2021 |
